Dokumendiregister | Ravimiamet |
Viit | MSO-2/1636-2 |
Registreeritud | 28.03.2025 |
Sünkroonitud | 31.03.2025 |
Liik | Väljaminev kiri |
Funktsioon | MSO Meditsiiniseadmed |
Sari | MSO-2 Eesti turule lastavate/kasutusele võetavate/levitatavate seadmete teavitused ning EC sertifikaadid |
Toimik | MSO-2/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | COMPLIFE ITALIA |
Saabumis/saatmisviis | COMPLIFE ITALIA |
Vastutaja | Maarika Ojala (RA, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: RA MSO <[email protected]>
Sent: Fri, 28 Mar 2025 08:23:33 +0000
To: "[email protected]" <[email protected]>
Cc: RA MSO <[email protected]>
Subject: FW: MEDICAL DEVICE NOTIFICATION
Dear Annamaria Mastropietro,
Thank you for your enquiry.
National requirements for medical devices are established in the Medical Devices Act. There is a distribution notification obligation for medical devices in Estonia and it is set out in the Medical Devices Act, §26 (4):
Every undertaking who distributes on the market of Estonia a system or procedure pack of medical devices according to Article 22 of Regulation (EU) 2017/745 of the European Parliament and of the Council or a class IIa, IIb or III medical device classified according to Regulation (EU) 2017/745 of the European Parliament and of the Council or Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices (OJ L 189, 20.07.1990, p 17–36) or Council Directive 93/42/EEC concerning medical devices (OJ L 169, 12.07.1993, p 1–43) or class B, C or D in vitro diagnostic medical devices classified according to Annex VIII of Regulation (EU) 2017/746 of the European Parliament and of the Council, shall notify the State Agency of Medicines thereof within 10 days after distribution of the relevant medical device for the first time.
Notification about distribution can be completed through our national Medical Devices and Appliances Database, https://msa.sm.ee/eng
Best regards,
Maarika Ojala
Specialist
Department of Medical Devices
State Agency of Medicines
1 Nooruse Street
50411 Tartu
Estonia
Phone: +372 737 4140
Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri.
This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal.
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Küsimused | 28.03.2025 | 3 | MSO-2/1636-1 | Sissetulev kiri | ra | COMPLIFE ITALIA |